Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138831780> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W2138831780 abstract "Clark DM, Ehlers A, McManus F, et al . Cognitive therapy versus fluoxetine in generalized social phobia: a randomized placebo-controlled trial. J Consult Clin Psychology 2003;71:1058–67.[OpenUrl][1][CrossRef][2][PubMed][3][Web of Science][4] Q What is the efficacy of cognitive therapy or fluoxetine in people with generalised social phobia? ### ![Graphic][5] Design:Randomised placebo controlled trial.### ![Graphic][6] Allocation:Concealed for the two arms receiving medication.### ![Graphic][7] Blinding:Double blind, for the two arms receiving medication.### ![Graphic][8] Follow up period:Twelve months.### ![Graphic][9] Setting:Institute of Psychiatry, London, UK; timeframe not stated.### ![Graphic][10] Patients:Sixty people (31 female, 29 male) meeting DSM IV criteria for generalised social phobia, selected from 123 possible candidates. Mean age 33.2 years. Treatment groups similar with respect to marital and employment status, and education. Exclusions: major depressive disorder, bipolar disorder, psychosis, epilepsy, borderline personality disorder, alcohol or substance dependence, previous treatment with SSRI, exposure therapy or cognitive therapy, refusal to withdraw from psychotropic medication 4 weeks before trial.### ![Graphic][11] Intervention:For 16 weeks, three groups of 20 people received cognitive therapy (see www.ebmentalhealth.com/supplemental for further details), fluoxetine … [1]: {openurl}?query=rft.jtitle%253DJournal%2Bof%2Bconsulting%2Band%2Bclinical%2Bpsychology%26rft.stitle%253DJ%2BConsult%2BClin%2BPsychol%26rft.aulast%253DClark%26rft.auinit1%253DD.%2BM.%26rft.volume%253D71%26rft.issue%253D6%26rft.spage%253D1058%26rft.epage%253D1067%26rft.atitle%253DCognitive%2Btherapy%2Bversus%2Bfluoxetine%2Bin%2Bgeneralized%2Bsocial%2Bphobia%253A%2Ba%2Brandomized%2Bplacebo-controlled%2Btrial.%26rft_id%253Dinfo%253Adoi%252F10.1037%252F0022-006X.71.6.1058%26rft_id%253Dinfo%253Apmid%252F14622081%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [2]: /lookup/external-ref?access_num=10.1037/0022-006X.71.6.1058&link_type=DOI [3]: /lookup/external-ref?access_num=14622081&link_type=MED&atom=%2Febmental%2F7%2F3%2F75.atom [4]: /lookup/external-ref?access_num=000186693600011&link_type=ISI [5]: /embed/inline-graphic-1.gif [6]: /embed/inline-graphic-2.gif [7]: /embed/inline-graphic-3.gif [8]: /embed/inline-graphic-4.gif [9]: /embed/inline-graphic-5.gif [10]: /embed/inline-graphic-6.gif [11]: /embed/inline-graphic-7.gif" @default.
- W2138831780 created "2016-06-24" @default.
- W2138831780 creator A5007095978 @default.
- W2138831780 date "2004-08-01" @default.
- W2138831780 modified "2023-09-26" @default.
- W2138831780 title "Cognitive therapy is more effective than fluoxetine in people with generalised social phobia" @default.
- W2138831780 cites W2039164918 @default.
- W2138831780 cites W2159011576 @default.
- W2138831780 cites W2167183710 @default.
- W2138831780 doi "https://doi.org/10.1136/ebmh.7.3.75" @default.
- W2138831780 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15273219" @default.
- W2138831780 hasPublicationYear "2004" @default.
- W2138831780 type Work @default.
- W2138831780 sameAs 2138831780 @default.
- W2138831780 citedByCount "0" @default.
- W2138831780 crossrefType "journal-article" @default.
- W2138831780 hasAuthorship W2138831780A5007095978 @default.
- W2138831780 hasBestOaLocation W21388317801 @default.
- W2138831780 hasConcept C118552586 @default.
- W2138831780 hasConcept C126322002 @default.
- W2138831780 hasConcept C142724271 @default.
- W2138831780 hasConcept C15744967 @default.
- W2138831780 hasConcept C168563851 @default.
- W2138831780 hasConcept C170493617 @default.
- W2138831780 hasConcept C204787440 @default.
- W2138831780 hasConcept C27081682 @default.
- W2138831780 hasConcept C2775864247 @default.
- W2138831780 hasConcept C2776134451 @default.
- W2138831780 hasConcept C2778455770 @default.
- W2138831780 hasConcept C71924100 @default.
- W2138831780 hasConceptScore W2138831780C118552586 @default.
- W2138831780 hasConceptScore W2138831780C126322002 @default.
- W2138831780 hasConceptScore W2138831780C142724271 @default.
- W2138831780 hasConceptScore W2138831780C15744967 @default.
- W2138831780 hasConceptScore W2138831780C168563851 @default.
- W2138831780 hasConceptScore W2138831780C170493617 @default.
- W2138831780 hasConceptScore W2138831780C204787440 @default.
- W2138831780 hasConceptScore W2138831780C27081682 @default.
- W2138831780 hasConceptScore W2138831780C2775864247 @default.
- W2138831780 hasConceptScore W2138831780C2776134451 @default.
- W2138831780 hasConceptScore W2138831780C2778455770 @default.
- W2138831780 hasConceptScore W2138831780C71924100 @default.
- W2138831780 hasLocation W21388317801 @default.
- W2138831780 hasLocation W21388317802 @default.
- W2138831780 hasOpenAccess W2138831780 @default.
- W2138831780 hasPrimaryLocation W21388317801 @default.
- W2138831780 hasRelatedWork W2068974727 @default.
- W2138831780 hasRelatedWork W2087384689 @default.
- W2138831780 hasRelatedWork W2090741735 @default.
- W2138831780 hasRelatedWork W2127620665 @default.
- W2138831780 hasRelatedWork W2337508805 @default.
- W2138831780 hasRelatedWork W2488839582 @default.
- W2138831780 hasRelatedWork W2912537462 @default.
- W2138831780 hasRelatedWork W2937907144 @default.
- W2138831780 hasRelatedWork W2966230561 @default.
- W2138831780 hasRelatedWork W3024118414 @default.
- W2138831780 isParatext "false" @default.
- W2138831780 isRetracted "false" @default.
- W2138831780 magId "2138831780" @default.
- W2138831780 workType "article" @default.
!["Clark DM, Ehlers A, McManus F, et al . Cognitive therapy versus fluoxetine in generalized social phobia: a randomized placebo-controlled trial. J Consult Clin Psychology 2003;71:1058–67.[OpenUrl][1][CrossRef][2][PubMed][3][Web of Science][4] Q What is the efficacy of cognitive therapy or fluoxetine in people with generalised social phobia? ### ![Graphic][5] Design:Randomised placebo controlled trial.### ![Graphic][6] Allocation:Concealed for the two arms receiving medication.### ![Graphic][7] Blinding:Double blind, for the two arms receiving medication.### ![Graphic][8] Follow up period:Twelve months.### ![Graphic][9] Setting:Institute of Psychiatry, London, UK; timeframe not stated.### ![Graphic][10] Patients:Sixty people (31 female, 29 male) meeting DSM IV criteria for generalised social phobia, selected from 123 possible candidates. Mean age 33.2 years. Treatment groups similar with respect to marital and employment status, and education. Exclusions: major depressive disorder, bipolar disorder, psychosis, epilepsy, borderline personality disorder, alcohol or substance dependence, previous treatment with SSRI, exposure therapy or cognitive therapy, refusal to withdraw from psychotropic medication 4 weeks before trial.### ![Graphic][11] Intervention:For 16 weeks, three groups of 20 people received cognitive therapy (see www.ebmentalhealth.com/supplemental for further details), fluoxetine … [1]: {openurl}?query=rft.jtitle%253DJournal%2Bof%2Bconsulting%2Band%2Bclinical%2Bpsychology%26rft.stitle%253DJ%2BConsult%2BClin%2BPsychol%26rft.aulast%253DClark%26rft.auinit1%253DD.%2BM.%26rft.volume%253D71%26rft.issue%253D6%26rft.spage%253D1058%26rft.epage%253D1067%26rft.atitle%253DCognitive%2Btherapy%2Bversus%2Bfluoxetine%2Bin%2Bgeneralized%2Bsocial%2Bphobia%253A%2Ba%2Brandomized%2Bplacebo-controlled%2Btrial.%26rft_id%253Dinfo%253Adoi%252F10.1037%252F0022-006X.71.6.1058%26rft_id%253Dinfo%253Apmid%252F14622081%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [2]: /lookup/external-ref?access_num=10.1037/0022-006X.71.6.1058&link_type=DOI [3]: /lookup/external-ref?access_num=14622081&link_type=MED&atom=%2Febmental%2F7%2F3%2F75.atom [4]: /lookup/external-ref?access_num=000186693600011&link_type=ISI [5]: /embed/inline-graphic-1.gif [6]: /embed/inline-graphic-2.gif [7]: /embed/inline-graphic-3.gif [8]: /embed/inline-graphic-4.gif [9]: /embed/inline-graphic-5.gif [10]: /embed/inline-graphic-6.gif [11]: /embed/inline-graphic-7.gif"](?object=%22Clark%20DM%2C%20Ehlers%20A%2C%20McManus%20F%2C%20et%20al%20.%20Cognitive%20therapy%20versus%20fluoxetine%20in%20generalized%20social%20phobia%3A%20a%20randomized%20placebo-controlled%20trial.%20J%20Consult%20Clin%20Psychology%202003%3B71%3A1058%E2%80%9367.%5BOpenUrl%5D%5B1%5D%5BCrossRef%5D%5B2%5D%5BPubMed%5D%5B3%5D%5BWeb%20of%20Science%5D%5B4%5D%E2%80%A8%20Q%20What%20is%20the%20efficacy%20of%20cognitive%20therapy%20or%20fluoxetine%20in%20people%20with%20generalised%20social%20phobia%3F%20%23%23%23%20!%5BGraphic%5D%5B5%5D%20Design%3ARandomised%20placebo%20controlled%20trial.%23%23%23%20!%5BGraphic%5D%5B6%5D%20Allocation%3AConcealed%20for%20the%20two%20arms%20receiving%20medication.%23%23%23%20!%5BGraphic%5D%5B7%5D%20Blinding%3ADouble%20blind%2C%20for%20the%20two%20arms%20receiving%20medication.%23%23%23%20!%5BGraphic%5D%5B8%5D%20Follow%20up%20period%3ATwelve%20months.%23%23%23%20!%5BGraphic%5D%5B9%5D%20Setting%3AInstitute%20of%20Psychiatry%2C%20London%2C%20UK%3B%20timeframe%20not%20stated.%23%23%23%20!%5BGraphic%5D%5B10%5D%20Patients%3ASixty%20people%20(31%20female%2C%2029%20male)%20meeting%20DSM%20IV%20criteria%20for%20generalised%20social%20phobia%2C%20selected%20from%20123%20possible%20candidates.%20Mean%20age%2033.2%20years.%20Treatment%20groups%20similar%20with%20respect%20to%20marital%20and%20employment%20status%2C%20and%20education.%20Exclusions%3A%20major%20depressive%20disorder%2C%20bipolar%20disorder%2C%20psychosis%2C%20epilepsy%2C%20borderline%20personality%20disorder%2C%20alcohol%20or%20substance%20dependence%2C%20previous%20treatment%20with%20SSRI%2C%20exposure%20therapy%20or%20cognitive%20therapy%2C%20refusal%20to%20withdraw%20from%20psychotropic%20medication%204%20weeks%20before%20trial.%23%23%23%20!%5BGraphic%5D%5B11%5D%20Intervention%3AFor%2016%20weeks%2C%20three%20groups%20of%2020%20people%20received%20cognitive%20therapy%20(see%20www.ebmentalhealth.com%2Fsupplemental%20for%20further%20details)%2C%20fluoxetine%20%E2%80%A6%20%5B1%5D%3A%20%7Bopenurl%7D%3Fquery%3Drft.jtitle%25253DJournal%252Bof%252Bconsulting%252Band%252Bclinical%252Bpsychology%2526rft.stitle%25253DJ%252BConsult%252BClin%252BPsychol%2526rft.aulast%25253DClark%2526rft.auinit1%25253DD.%252BM.%2526rft.volume%25253D71%2526rft.issue%25253D6%2526rft.spage%25253D1058%2526rft.epage%25253D1067%2526rft.atitle%25253DCognitive%252Btherapy%252Bversus%252Bfluoxetine%252Bin%252Bgeneralized%252Bsocial%252Bphobia%25253A%252Ba%252Brandomized%252Bplacebo-controlled%252Btrial.%2526rft_id%25253Dinfo%25253Adoi%25252F10.1037%25252F0022-006X.71.6.1058%2526rft_id%25253Dinfo%25253Apmid%25252F14622081%2526rft.genre%25253Darticle%2526rft_val_fmt%25253Dinfo%25253Aofi%25252Ffmt%25253Akev%25253Amtx%25253Ajournal%2526ctx_ver%25253DZ39.88-2004%2526url_ver%25253DZ39.88-2004%2526url_ctx_fmt%25253Dinfo%25253Aofi%25252Ffmt%25253Akev%25253Amtx%25253Actx%20%5B2%5D%3A%20%2Flookup%2Fexternal-ref%3Faccess_num%3D10.1037%2F0022-006X.71.6.1058%26link_type%3DDOI%20%5B3%5D%3A%20%2Flookup%2Fexternal-ref%3Faccess_num%3D14622081%26link_type%3DMED%26atom%3D%252Febmental%252F7%252F3%252F75.atom%20%5B4%5D%3A%20%2Flookup%2Fexternal-ref%3Faccess_num%3D000186693600011%26link_type%3DISI%20%5B5%5D%3A%20%2Fembed%2Finline-graphic-1.gif%20%5B6%5D%3A%20%2Fembed%2Finline-graphic-2.gif%20%5B7%5D%3A%20%2Fembed%2Finline-graphic-3.gif%20%5B8%5D%3A%20%2Fembed%2Finline-graphic-4.gif%20%5B9%5D%3A%20%2Fembed%2Finline-graphic-5.gif%20%5B10%5D%3A%20%2Fembed%2Finline-graphic-6.gif%20%5B11%5D%3A%20%2Fembed%2Finline-graphic-7.gif%22){kind=link}